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CalciumIn this study, we demonstrated the molecular mechanisms of TGF-β1 induction as well as proteolytic
activation in HCV (JFH-1)-infected cells. Our studies showed the synthesis and secretion of TGF-β1 in HCV-
infected cells which was reduced in the presence of Ca2+ chelators, an inhibitor of mitochondrial Ca2+ uptake,
and antioxidants. We also showed that the expression of HCV NS proteins NS3/4A, and NS5A can induce TGF-
β1 by cell-based luciferase assay. Furthermore, mutational analysis revealed that the functionally active
protease domain of NS3 and N-terminus domain of NS5A are required for TGF-β1 activity. Using siRNA
approach we demonstrated that HCV-induced furin and thrombospondin-1 (TSP-1) are involved in the
proteolytic activation of TGF-β1. Our results also suggest that TGF-β1 positively regulates HCV RNA
replication. Collectively, these observations provide insight into the mechanism of TGF-β1 activation, which
likely manifest in liver ﬁbrosis associated with hepatitis C infection.G. Waris).
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Hepatitis C virus (HCV) often causes persistent infection in humans,
which may lead to chronic hepatitis in up to 60–80% of infected adults
and can progress to liver ﬁbrosis, cirrhosis, and eventually hepatocel-
lular carcinoma (HCC) (Di Bisceglie, 1997). HCV is an enveloped,
single-stranded, positive-sense RNA virus which is approximately
9.6 kb in length, and encodes a single polyprotein of about 3000 amino
acids (Bartenschlager and Lohmann, 2000). The viral polyprotein is
cleaved by host and viral proteases, into three structural (core, E1 and
E2) and seven non-structural (p7, NS2, NS3–NS5A/B) proteins
(Grakoui et al., 1993; Lohmann et al., 1996). The single open reading
frame (ORF) is ﬂanked by 5′- and 3′-nontranslated regions (NTRs),
which have been shown to be essential in both initiation of translation
and viral RNA replication (Bartenschlager and Lohmann, 2000).
Previously, the studies of molecular mechanisms of HCV replication
and pathogenesis have been hampered by the lack of an efﬁcient cell
culture system and a suitable small-animal model. The development of
a robust and productive HCV (genotype 2a) infection system has
provided a major breakthrough which allows the production of
infectious virus in cell culture (Lindenbach et al., 2005; Wakita et al.,
2005; Zhong et al., 2005).
Calcium-mediated mitochondrial dysfunction has been suggested
to play an important role in HCV-induced liver disease pathogenesis(Piccoli et al., 2007). Previously, we have shown that HCV gene
expression in the endoplasmic reticulum (ER) induces ER stress with
depletion of ER Ca2+ levels (Benali-Furet et al., 2005; Tardif et al.,
2004, 2005). The concentration of Ca2+ released from the ER may be
high enough to switch on the “low afﬁnity” mitochondrial uniporter
(Rizzuto and Pozzan, 2006). The uptake of Ca2+ by the mitochondria
subsequently results in the generation of reactive oxygen species
(ROS) (Waris et al., 2002). The elevated levels of ROS have emerged as
a key player in the progression of HCV-induced liver disease
pathogenesis (Machida et al., 2006; Pal et al., 2010). Previously, we
have shown that HCV gene expression in the ER induces oxidative
stress through deregulated Ca2+ signaling in the ER (Burdette et al.,
2010; Gong et al., 2001; Tardif et al., 2005). Several HCV proteins
including core, NS3, NS5A, and HCV subgenomic replicon have been
shown to induce ROS in human hepatoma cells (Bureau et al., 2001;
Gong et al., 2001; Kasprzak and Adamek, 2008; Machida et al., 2006;
Okuda et al., 2002; Waris et al., 2005). ROS is known to up-regulate
the synthesis of TGF-β1 and collagen gene expression, hallmarks of
liver ﬁbrosis.
The molecular mechanisms underlying liver injury and ﬁbrosis in
chronic HCV remain unclear. It has been postulated that immune-
mediated damage is linked to ﬁbrosis, where cytokines including
TGF-β1 play a prominent role (Schuppan et al., 2003). TGF-β1 is a
pleiotropic cytokine that plays a role in tumor suppression as well as
tumor progression (Bissell et al., 2001). Most tumors progress and
metastasize in the presence of high levels of TGF-β1. It has been
reported that HCV infection is associated with a signiﬁcant increase
in TGF-β1 expression in both serum and liver (Grungreiff et al.,
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secreted mainly from Kupffer cells and activated hepatic stellate
cells (HSCs). Normal hepatocytes only secrete a small amount of
TGF-β1. Previous studies suggest that HCV core proteins and
subgenomic replicons can directly induce TGF-β1 gene expression
in hepatocytes (Schulze-Krebs et al., 2005; Taniguchi et al., 2004).
However, the molecular mechanisms of TGF-β1 induction and its
proteolytic activation into bioactive TGF-β1 in HCV-infected hepa-
tocytes are unclear. Recently, endogenous TGF-β1 has been shown
to induce intracellular signaling pathways (McMahon et al., 2006).
Furin is the best characterized member of the mammalian
proprotein convertases family that is responsible for pro-TGF-β1
proteolytic processing (Dubois et al., 1995).
As cytokines can play major roles in pathogenesis during the
courses of viral infection, the relationships between HCV replication
and TGF-β1 is of great importance. The role of TGF-β1 in HCV
replication is not clearly deﬁned. The serological investigations of
HCV in chronically infected patients imply an inverse relationship
between viremia and TGF-β1 levels (Adinolﬁ et al., 2001). Recently,
the stimulation as well as suppression of HCV replication by
exogenously added TGF-β1 has been demonstrated in HCV subge-
nomic replicon system (Hosui et al., 2009; Lin et al., 2008).
Herein, we demonstrate the induction, proteolytic activation, and
secretion of bioactive TGF-β1 in HCV cell culture infection system.We
demonstrate that the activation of TGF-β1 in HCV-infected cells is
mediated by Ca2+ signaling in the ER and elevation of ROS in the
mitochondria. Further, our results show that HCVNS proteins NS3 and
NS5A are critical for TGF-β1 activation and secretion. Next, we
evaluated that proprotein convertases furin and TSP-1 were respon-
sible for proteolytic cleavage of pro-TGF-β1 into bioactive form in
HCV-infected cells. Using siRNA against furin, TSP-1, and TGF-β1, we
also observed a decrease in HCV replication. These data collectively
demonstrate mechanisms for TGF-β1 induction and proteolytic
activation by HCV.
Results
HCV infection induces TGF-β1
In this study, we investigated the molecular mechanisms of TGF-
β1 induction as well as proteolytic activation of TGF-β1 by HCV
infection (JFH-1). We ﬁrst examined whether HCV infection in human
hepatoma cell line (Huh-7) induces TGF-β1. Huh-7 cells were
incubated with HCV cell culture supernatant as described previously
(Burdette et al., 2010; Waris et al., 2007). To demonstrate the level of
HCV infection in Huh-7 cells, total cellular RNA was harvested at the
indicated time points and subjected to quantitative RT-PCR. We
observed a 4 fold increase in HCV replication at day 2, increasing to 15
fold at day 3 compared to mock-infected Huh-7 cells (Fig. 1A). To
determine the levels of HCV protein expression in HCV-infected cells,
total cellular lysates were subjected to immunoblot analysis. The
results show HCV core protein expression at days 2 and 3 (Fig. 1A,
lanes 3 and 4).
To determine if HCV-infected Huh-7 cells secrete cytokines and
growth factors, cell culture supernatant frommock-infected and HCV-
infected Huh-7 cells was collected and subjected to cytokine array.
The results show about a 6 fold increase in secretion of TGF-β1, a 4.5
fold increase in platelet derived growth factor-BB (PDGF-BB), a 6 fold
increase in angiogenin, a 7 fold increase in VEGF, a 5 fold increase in
EGF, and an 8 fold increase in TNF-α in HCV-infected Huh-7 cells
(Fig. 1B). However, the levels of IGF, TNF-β, MCSF, and MCP-1 were
not signiﬁcantly changed. These results suggest that HCV-infected
Huh-7 cells can secrete proﬁbrogenic factors such as TGF-β1 and
PDGF-BB in HCV-infected cells.
Since TGF-β1 is the major cytokine that regulates hepatic
ﬁbrogenesis (Bissell et al., 2001), it is critical to examine the kineticsof TGF-β1 activation in the context of HCV-infection. To conﬁrm that
HCV-infected cells secrete TGF-β1, cell culture supernatant was
collected from mock and HCV-infected Huh-7 cells and subjected to
TGF-β1-speciﬁc enzyme-linked immunosorbent assay (ELISA) analy-
sis. The results revealed the secretion of TGF-β1 (724 pg/ml) at day 2
postinfection (Fig. 1C) and peaked at day 3 postinfection (1453 pg/ml)
compared to cell culture supernatant collected from mock-infected
Huh-7 cells at days 1, 2, and 3 (Fig. 1C).
To determine whether HCV infection induces TGF-β1 mRNA
expression, total cellular RNA was extracted from mock-infected
and HCV-infected Huh-7 cells and the level of TGF-β1 mRNA was
quantiﬁed by real-time RT-PCR. The results showed an increase in
TGF-β1 mRNA levels in Huh-7 cells infected with HCV in a time-
dependent manner and peaked at day 3 (about 3.6 fold) compared to
Huh-7 cells mRNA collected at days 1, 2, and 3 (Fig. 1D). Taken
together these results clearly indicate that HCV-infection in Huh-7
cells induces transcriptional stimulation, synthesis, and secretion of
bioactive TGF-β1.
Role of HCV proteins on TGF-β1 induction
In order to identify the HCV protein(s) responsible for TGF-β1
induction, we performed TGF-β1 promoter-luciferase reporter assay.
Huh-7 cells were transiently-transfected with wild-type TGF-β1
promoter-luciferase reporter (phTG1−1362/+11) along with various
HCV protein expression vectors and were subjected to dual-luciferase
assay. We observed an increase in TGF-β1 promoter-luciferase activity
by core (~2.5 fold), NS3 (~2.5 fold), NS3/4A (~4 fold), and NS5A (~4
fold) (Fig. 2A). In contrast, the expression of HCV E1/E2, NS4B, andNS5B
did not show any signiﬁcant effect on TGF-β1 promoter-luciferase
activity.
To determine if HCV protein expression can induce TGF-β1
secretion, cell culture supernatant was collected and subjected to
TGF-β1 speciﬁc ELISA analysis. The results show the increased
secretion of TGF-β1 in the cell culture supernatant of Huh-7 cells
transfected with core (375 pg/ml), NS3 (474.56 pg/ml), NS3/4A
(774 pg/ml), NS4B (275 pg/ml), and NS5A (574 pg/ml) (Fig. 2B).
The expression of E1/E2 and NS5B did not induce TGF-β1 secretion
(Fig. 2B). To determine the expression of various HCV proteins in
Huh-7 cells, cellular lysates were immunoblotted for respective HCV
proteins (Fig. 2C). These results suggest that among HCV NS proteins
NS3/4A and NS5A are critical in TGF-β1 induction and secretion.
Effect of NS3/4A mutations on TGF-β1 induction
To identify the domain(s) of NS3/4A which is responsible for
TGF-β1 promoter activity, deletion and point mutations of NS3/4A
were used in this study (Li et al., 2005). Huh-7 cells were
transfected with wild-type TGF-β1 promoter-luciferase reporter
along with the wild-type pNS3, pNS3/4A, or mutant expression
vectors pNS3/4A (Δ1487–1501) and pNS3/4A (S1156A). Cellular
lysates were collected and subjected to dual-luciferase assay. The
results indicate approximately 4 fold increase in NS3/4A mediated
TGF-β1 promoter activity which was decreased in the presence of
NS3/4A deletion or point mutations (Fig. 3A). These results suggest
that proteolytically active NS3/4A complex is required to activate
TGF-β1 promoter.
To determine the effect of NS3/4A mutations on TGF-β1
secretion, cell culture supernatants were collected and subjected to
TGF-β1 ELISA analysis. The results show the increased secretion of
TGF-β1 in the cell culture supernatant of Huh-7 cells transfected
with NS3 (453 pg/ml), NS3/4A (631 pg/ml), pNS3/4A (Δ1487–1501)
(382 pg/ml) and pNS3/4A (S1156A) (334 pg/ml) (Fig. 3B). These
results indicate that HCV NS3 alone or NS3/4A mutants were unable
to induce TGF-β1 secretion as efﬁciently as HCV NS3/4A protein. The
expressions of wild-type and mutant NS3/4A proteins were shown
Fig. 1. (A) HCV-infection induces TGF-β1. Total cellular RNAwas extracted at various time points and the levels of HCV RNAwere determined by quantitative RT-PCR. The data shown
here represent the means±sd of at least three independent experiments performed in triplicate. * denotes pb0.05 compared to HCV-infected cells at day 1. Cellular lysates from
these cells were subjected to immunoblot analysis using antibodies against HCV core and actin. (B) Secretion of cytokines and growth factors fromHCV-infected cells. The cell culture
supernatant frommock- and HCV-infected Huh-7 cells at day 3 was collected and subjected to RayBiotech cytokine array. * denotes pb0.05 compared to mock-infected Huh-7 cells.
(C) Secretion of TGF-β1 in cell culture supernatant. The secreted TGF-β1 protein in cell culture supernatant after HCV infection was determined by ELISA. * denotes pb0.05 compared
to HCV-infected cells at day 1. (D) Transcriptional stimulation of TGF-β1 mRNA in HCV-infected cells. Total cellular RNA was extracted frommock-infected and HCV-infected Huh-7
cells. TGF-β1 mRNA was analyzed using TGF-β1-speciﬁc primers. The values represent the means±sd of three independent experiments performed in triplicate. * denotes pb0.05
compared to HCV-infected cells at day 1.
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1501) was low and a similar expression pattern was observed
previously (Johnson et al., 2007).
Effect of NS5A mutations on TGF-β1 induction
To determine the region(s) of NS5A which is involved in
induction of the TGF-β1 promoter, various NS5A deletion mutations
were used (Gong et al., 2001). Huh-7 cells were transfected with
wild-type TGF-β1 promoter luciferase construct along with the
wild-type or mutant NS5A expression vectors. The NS5A mutant,
pCNSM1 is a N-terminal deletion mutant, pCNSM3 is a C-terminal
deletion mutant. Cellular lysates were collected and subjected to
dual-luciferase assay. The results indicate an approximately 4 fold
increase in wild-type NS5A-mediated TGF-β1 promoter activity
(Fig. 3E), which was efﬁciently reduced in the presence of pCNSM1;
however, pCNSM3 did not affect the TGF-β1 promoter activity.
These results suggest that the N′-terminal 163 amino acids (aa) of
NS5A are important for activation of the TGF-β1 promoter reporter.
To determine the effect of NS5A mutations on TGF-β1 secretion,
cell culture supernatants were collected and subjected to TGF-β1
speciﬁc ELISA analysis. The results show the increased secretion of
TGF-β1 in the cell culture supernatant of Huh-7 cells transfected with
NS5A wild-type (600 pg/ml), and pCNSM3 (495 pg/ml). The NS5A
mutant pCNSM1 (200 pg/ml) was impaired in inducing secreted TGF-β1 (Fig. 3F). The expression of wild-type NS5A (58 kDa), pCNSM1
(31 kDa), and pCNSM3 (18 kDa) was shown by western blotting
(Fig. 3G).
Role of HCV-induced Ca2+ signaling and elevation of ROS on
TGF-β1 induction
To determine if HCV-induced Ca2+ efﬂux from the ER and induction
of ROS in themitochondria play a key role in TGF-β1 induction, we ﬁrst
established that HCV-infection induces ROS via Ca2+ signaling in the
ER. Mock-infected andHCV-infected cells were incubatedwith calcium
chelators (BAPTA-AM, or TMB-8), an inhibitor of mitochondrial Ca2+
uptake (ruthenium red) and were assayed for ROS by ﬂow cytometry.
The results show an increase in ROS in HCV-infected cells, which was
reduced in the presence of BAPTA-AM, TMB-8, or ruthenium red,
(Fig. 4A). Mock-infected cells treated with these inhibitors did not
show any effect. Huh-7 cells incubated with hydrogen peroxide were
used as a positive control (Fig. 4B). To further conﬁrm the induction of
ROS through Ca2+ signaling, cells were visualized by microscopy. The
results show an increase in ROS in HCV-infected cells which was
reduced in the presence of calcium inhibitors (BAPTA-AM, TMB-8, or
ruthenium red) (Fig. 4C). The expression of HCV core represents the
HCV-infection (Fig. 4D, lane 2). These results suggest that HCV-
mediated Ca2+ signaling in the ER induces ROS production in the
mitochondria.
Fig. 2. (A) Role of HCV proteins on TGF-β1 induction. Huh-7 cells were transfected with wild-type TGF-β1 promoter luciferase reporter (phTG −1362/+11) (500 ng), and HCV
protein expression vectors or vector control (250 ng) using Lipofectamine 2000 according to the manufacturer's instructions. The cellular lysates were subjected to dual luciferase
reporter assay. The values represent the means±standard deviations of three independent experiments performed in triplicate. * denotes pb0.05 compared to vector control
transfected cells. (B) Secretion of TGF-β1 in Huh-7 cells transfected with HCV protein expression vectors. Total secreted TGF-β1 protein in cell culture supernatant was determined
by ELISA. The values represent the means±standard deviations of three independent experiments performed in triplicate. * denotes pb0.05 compared to vector control transfected
cells. (C) Cellular lysates from Huh-7 cells transfected with various HCV proteins, were immunoblotted with antibodies against core, E1/E2, NS3, NS4B, NS5A, NS5B, and actin.
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wild-type TGF-β1 promoter luciferase activity, mock-infected and
HCV-infected Huh-7 cells were transfected with wild-type TGF-β1
promoter-luciferase reporter. The cells were incubatedwith non-toxic
doses of speciﬁc Ca2+ chelators (BAPTA-AM, and TMB-8), speciﬁc
inhibitors of mitochondrial Ca2+ uptake (ruthenium red), antiox-
idants (PDTC) and an inhibitor of ROS generated through NADPH
oxidase system (DPI). The results show a 5 fold increase in TGF-β1
promoter activity by HCV infection (Fig. 5A) which was decreased in
HCV-infected cells treated with BAPTA-AM, ruthenium red, or TMB-8.
However, treatment with EGTA (an extracellular Ca2+ chelator) did
not show signiﬁcant reduction of wild-type TGF-β1 promoter activity
(Fig. 5A). Similarly, a decrease of TGF-β1 promoter activity in HCV-
infected cells treated with antioxidant PDTC was observed (Fig. 5A).
HCV-infected cells incubated with DPI did not reduce the TGF-β1
promoter activity. These inhibitors did not show any effect on TGF-β1
promoter activity in mock-infected cells (data not shown).
To further strengthen these results, we determined the effect of
Ca2+ signaling and elevation of ROS on endogenous TGF-β1 mRNA
expression. Mock-infected and HCV-infected cells were incubated
with various inhibitors as described above. The results show an ~4.5
fold increase in TGF-β1 mRNA expression by HCV infection (Fig. 5B)
which was reduced in HCV-infected cells treated with BAPTA-AM,
ruthenium red, or TMB-8 (Fig. 5B). However, treatmentwith EGTA did
not show a signiﬁcant reduction of TGF-β1 mRNA expression.
Similarly, a decrease of TGF-β1 mRNA expression in HCV-infected
cells treated with antioxidants PDTC and NAC was observed (Fig. 5B)but not with DPI treatment. These results suggest that HCV-mediated
Ca2+ signaling in the ER is critical for the generation of ROS in the
mitochondria which plays a key role in the activation of TGF-β1
promoter and expression of endogenous TGF-β1 mRNA.
Effect of HCV-induced proprotein convertases on proteolytic processing
of TGF-β1
There are numerous proprotein convertases that have been shown
to proteolytically activate TGF-β1 (Annes et al., 2003). To determine if
HCV-infection induces the expression of potential proprotein con-
vertases, total cellular RNA was harvested from mock-infected and
HCV-infected cells and quantitative RT-PCR was performed using
primers directed against potential proteases such as furin, thrombos-
pondin-1 (TSP-1), matrix metalloproteinase-9 (MMP-9) and calpain.
The results show the induction of furin (3 fold) and TSP-1 (5 fold)
mRNA in HCV-infected cells (Fig. 6A). The induction of calpain and
MMP-9 mRNA was not affected. To determine the protein expression,
cellular lysates and cell culture supernatant were collected from
mock-infected and HCV-infected cells and subjected to immunoblot
analysis. The results showed an increase in furin protein expression
and secretion of TSP-1 in HCV-infected cells compared to mock-
infected Huh-7 cells (Fig. 6B). To determine the proteolytic activation
of TGF-β1 in HCV-infected cells, cellular lysates were immunoblotted
using antibody against TGF-β1. The results displayed induction and
proteolytic cleavage of TGF-β1 into mature form in HCV-infected cells
(Fig. 6B, lane 2). These results show that HCV-infection induces
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sing of latent TGF-β1 into bioactive TGF-β1. To further conﬁrm the
expression of furin in HCV-infected cells, mock-infected and HCV-
infected cells were also subjected to immunoﬂuorescence analysis
using furin, TGF-β1, and HCV NS3 antibodies. The results show an
increased expression of furin, and TGF-β1, in a time-dependent
manner (Fig. 6C). We also observed the cytoplasmic localization of
TGF-β1 with furin in HCV-infected cells (Fig. 6C). These results
strengthen the notion that furin is induced by HCV infection and plays
an important role in the proteolytic processing of latent TGF-β1 into
bioactive form.
In order to demonstrate that HCV-induced furin or TSP-1 have an
effect on the proteolytic activation and subsequent secretion of TGF-
β1, mock-infected and HCV-infected cells were transfected with
siRNA directed against furin, TSP-1, TGF-β1, and GFP. To determine
the effect of the speciﬁc siRNA on the target gene expression, total
cellular RNA was collected and subjected to quantitative RT-PCR.
Fig. 7A shows a 50% decrease in furin mRNA expression after siRNA
transfection, an 80% decrease in TGF-β1 mRNA, and a 90% decrease in
TSP-1 mRNA expression. Cell culture supernatant from these siRNA
transfected cells were collected and subjected to TGF-β1-speciﬁc
ELISA analysis. The results show an increase in the secretion of TGF-β1
which was reduced in HCV-infected cells transfected with siRNA
against TGF-β1, furin, or TSP-1 (Fig. 7B). GFP siRNA was used as aFig. 3. (A) Effect of NS3/4A on TGF-β1 promoter luciferase activation. Huh-7 cells were tran
NS3, NS3/4A, NS3/4A (Δ1487–1501), and (S1156A) protein expression vectors or vector cont
values represent the means±standard deviations of three independent experiments per
** denotes pb0.05 compared to wild-type NS3/4A. (B) Secretion of TGF-β1 in Huh-7 cells tr
supernatant was harvested and total secreted TGF-β1 protein was determined by ELISA. Th
performed in triplicate. * denotes pb0.05 compared to vector control transfected cells. ** den
NS3/4A. Cellular lysates from Huh-7 cells transfected with NS3, NS3/4A, NS3/4A (Δ1487–15
(D) Schematic of NS3/4A domains. NS3 is composed of two domains; a serine protease dom
drawing represent the amino acids number of the HCV polyprotein. The star on the NS3/4A S
which ablates protease activity. (E) Effect of HCV NS5A on TGF-β1 induction. Huh-7 cells wer
and HCV NS5A and mutant expression vectors or vector control. At 36 h posttransfection, ce
standard deviations of three independent experiments performed in triplicate. * denotes pb
type NS5A. (F) Secretion of TGF-β1 in Huh-7 cells transfected with wild-type and mutant H
ELISA. The values represent the means±standard deviations of three independent experim
cells. ** denotes pb0.05 compared to wild-type NS5A. (G) The expression pattern of wild-ty
using Flag antibody. (H) Schematic of NS5A wild-type and deletion mutants. The dotted linnegative control. The detection of TGF-β1 in the cell culture
supernatant by this method does not differentiate between bioactive
and inactive TGF-β1.
HCV-infection induces secretion of bioactive TGF-β1
The bioactive TGF-β1 protein in cell culture supernatant was
quantiﬁed using a standard growth inhibition assay with mink lung
epithelial cells (MLEC) as described previously (Abe et al., 1994;
Schulze-Krebs et al., 2005). In this assay, MLEC stably transfected with
the PAI/L demonstrate a dose-dependent increase in luciferase
activity which indirectly corresponds to growth inhibition. MLEC
were incubated with cell culture supernatant from siRNA transfected
mock-infected and HCV-infected cells and subjected to luminescence
assay. The results show increased luciferase activity in HCV-infected
cells, which was reduced in HCV-infected cells transfected with TGF-
β1, furin, or TSP-1 (Fig. 7C). These results suggest that HCV infection
induces secretion of bioactive TGF-β1 through furin and TSP-1.
Effect of furin, TSP-1, and TGF-β1 on HCV replication
To evaluate the effect of furin, TSP-1, and TGF-β1 on HCV RNA
replication in HCV infected cells, we used RNA interference approach
as described in Fig. 7. Total cellular RNA was extracted from varioussfected with wild-type TGF-β1 promoter luciferase reporter (phTG −1362/+11), and
rol. At 36 h posttransfection, cellular lysates were subjected to dual luciferase assay. The
formed in triplicate. * denotes pb0.05 compared to vector control transfected cells.
ansfected with wild-type HCV NS3, NS3/4A and mutant expression vectors. Cell culture
e values represent the means±standard deviations of three independent experiments
otes pb0.05 compared towild-type NS3/4A. (C) The expression of wild-type andmutant
01), and NS3/4A (S1156A) were subjected to immunoblot analysis using Flag antibody.
ain and a nucleoside triphosphatase/DEXD/H box helicase domain. Numbers above the
1165A construct represents the serine 1165 (of the catalytic triad) mutation to alanine,
e transfected with wild-type TGF-β1 promoter luciferase reporter (phTG−1362/+11),
llular lysates were subjected to dual luciferase assay. The values represent the means±
0.05 compared to vector control transfected cells. ** denotes pb0.05 compared to wild-
CV NS5A. Total secreted TGF-β1 protein in cell culture supernatant was determined by
ents performed in triplicate. * denotes pb0.05 compared to vector control transfected
pe and mutant NS5A proteins. Cellular lysates were subjected to immunoblot analysis
es represent the extent of deletion of NS5A sequences.
Fig. 3 (continued).
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primers and Taqman probe. We observed an increased replication of
HCV RNA in HCV-infected cells (Fig. 8A), which was signiﬁcantly
reduced in HCV-infected cells in the presence of TGF-β1 siRNA, TSP-1
siRNA or furin siRNA, (Fig. 8A). However, transfection of GFP siRNA
(negative control) in HCV infected cells did not show any change in
HCV replication (Fig. 8A).
To evaluate the effect of the HCV RNA replication and transfection
of cells with TGF-β1, furin, or TSP-1 siRNA on cell proliferation, siRNA
transfected, mock-infected and HCV-infected cells were subjected to
MTT assay. The results show a proliferative effect of HCV replication
on Huh-7 cells, but there was no signiﬁcant proliferative effect after
siRNA transfections (Fig. 8B).Discussion
The molecular mechanisms underlying liver ﬁbrosis in chronic
hepatitis C are not clearly understood. TGF-β1 is a multifunctional
cytokine involved in the regulation of cell proliferation, differentiation
and liver ﬁbrogenesis (Jennings and Pietenpol, 1998; Kaminska et al.,
2005). Deregulation of TGF-β1 expression has been implicated in the
pathogenesis of various diseases including liver ﬁbrosis. TGF-β1
overexpression is frequently observed in human HCC (Rossmanith
and Schulte-Hermann, 2001). TGF-β1 can play a role of tumor
suppression as well as tumor progression (Bissell et al., 2001). There is
growing evidence that in the later stages of cancer development TGF-
β1 is actively secreted by tumor cells and contributes to cell growth,
invasion and metastasis (Jennings and Pietenpol, 1998). Previous
studies have shown that HCV-infection is associated with signiﬁcant
increase in inﬂammatory cytokines and growth factors including TGF-
β1 in both serum and liver (Blackard et al., 2006; Nelson et al., 1997).
It has been postulated that the host T-cell immune response to HCV-
infected hepatocytes is associated with release of cytokines and
growth factors, such as TGF-β1, TNF-α, PDGF, and IL-6, which activate
hepatic stellate cells to secrete extracellular matrix components.Most of the studies related to ﬁbrosis in the context of HCV have
been conducted in HSCs. In the absence of inﬂammation, liver TGF-β1
is secreted from HSC and Kupffer cells but not from hepatocytes.
However, upon inﬂammation or liver injury, hepatocytes gradually
become amajor source of TGF-β1 (Canbay et al., 2004; Gao et al., 1996;
Jeong et al., 2004; Takehara et al., 2004). The increased levels of hepatic
TGF-β1may enhance progression of liver ﬁbrosis in patients with HCV
(Wilson et al., 2006). HCV infects only hepatocytes in the liver and
induces chronic inﬂammation. No other nonparenchymal liver cells
are targets for HCV (Bataller et al., 2004). The possibility that HCV-
infected hepatocytes themselves produce proﬁbrogenic cytokines has
not been explored in detail. Previously, HCV has been shown to induce
TGF-β1 gene expression in human hepatoma cell lines (Taniguchi
et al., 2004). However, themolecularmechanisms of TGF-β1 induction
and posttranslational processing in the context of HCV-infection are
unclear. Recently, the intracellular processing of latent TGF-β1 before
secretion has been reported in liver tissue and primary hepatocytes
treated with carbon tetrachloride (CCl4) (Hosui et al., 2009).
In the present study, we investigated themolecular mechanisms of
TGF-β1 synthesis and its proteolytic activation using HCV cell culture
infection system. We observed that HCV-infection can induce and
secrete TGF-β1 in a time-dependent manner. This is consistent with
the previous studies in which HCV JFH-1 cell culture infection system
has been shown to induce TGF-β1 (Lin et al., 2010). The HCV
structural protein core and the nonstructural (NS) proteins NS3, NS4B,
and NS5A have been implicated in various signal transduction
pathways (Gouttenoire et al., 2001; Johnson et al., 2007; Li et al.,
2009; Macdonald and Harris, 2004). Previously, HCV core protein has
been shown to induce TGF-β1 in cultured cells (Taniguchi et al.,
2004). However, the determinants of HCV NS proteins responsible for
TGF-β1 induction have not been explored. The results described here
show that HCV NS3/4A is able to induce the TGF-β1 promoter,
implying that NS4A (a cofactor of NS3) is required to form a
functionally active protease domain. However, pNS3/4A (Δ1487–
1501) has little effect on wild-type TGF-β1 promoter activation
(Fig. 3A) as the mutation is outside the protease domain, however the
Fig. 4. Generation of ROS in HCV-infected cells. (A and B) Intracellular ROS levels weremeasured using CM-H2DCFDA. Mock- and HCV-infected cells were treated with Ca2+ chelators
or H2O2 followed by incubation with CM-H2DCFDA as described in Materials and methods. The ROS levels were analyzed using ﬂow cytometry. (C) Mock- and HCV-infected cells
were treated with calcium chelators followed by incubation with CM-H2DCFDA and the intracellular ROS levels were measured using microscopy. (D) Cellular lysates from Huh-7
and HCV-infected cells were subjected to immunoblot analysis using antibody against HCV core and actin.
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promoter activity because it results in an inactive NS3/4A protease
region. These results are consistent with the studies demonstrating
the role of various NS3 constructs along with cofactor NS4A in
inhibiting host antiviral signaling (Johnson et al., 2007).
HCV NS5A is part of the replication complex that catalyses
replication of the viral genome (Bartenschlager and Lohmann,
2000). NS5A has the potential to regulate not only interferon
responses but also many other cellular functions, such as mitogenic
signaling, apoptosis, cell cycle and ROS signaling, by interacting with a
variety of host proteins (Gong et al., 2001; Macdonald and Harris,
2004; Waris et al., 2002). Our results indicate that N′-terminal 163
amino acids are critical for the activation of TGF-β1. The N-terminal
domain of NS5A forms a highly conserved amphipathic alpha helix
and has been shown to associate with ER membrane and induce ER to
nucleus signal transduction pathway which can lead to chronic
inﬂammation and liver ﬁbrosis (Brass et al., 2002; Gong et al., 2001;
Waris et al., 2003). The N′-terminal deletion mutant (pCNSM1) did
not associate with ER membrane and unable to activate TGF-β1,
however, C-terminal deletionmutant (pCNSM3) was able to associate
with ER and induce the activation of TGF-β1 (Figs. 3E–H).
HCV nonstructural proteins associate with the ERmembrane in the
reticular network of the perinuclear region and are believed to form a
ribonucleoprotein complex along with the viral RNA genome that
engages in RNA replication (Bartenschlager and Lohmann, 2000). HCV
gene expression in the ER causes induction of ER stress (Gong et al.,
2001). One of the consequences of the ER stress response is Ca2+
release from the ER, uptake of Ca2+ by the mitochondrial uniporter,followed by oxidative stress via elevation of ROS in the mitochondria
(Burdette et al., 2010; Gong et al., 2001;Waris et al., 2007). Our results
show that HCV-infection activates TGF-β1 via Ca2+ signaling and
induction of oxidative stress. This is consistent with the previous
observations that activation of TGF-β1 occurs under condition of
oxidative stress (Lin et al., 2010). In contrast to these studies,
according to our model, ROS is generated in themitochondria through
the assembly of HCV replicase complex in the perinuclear membrane
of the ER. This association leads to Ca2+ efﬂux from the ER and
generation of ROS (Fig. 9, model). Calcium-mediated mitochondrial
dysfunction has been suggested to play an important role in HCV-
induced liver disease pathogenesis (Piccoli et al., 2007). Our results
clearly demonstrate the inhibition of TGF-β1 activity using antiox-
idants, PDTC and NAC but an insigniﬁcant decrease using DPI (an
inhibitor of ROS generated through NADPH oxidase system),
suggesting that ROS is generated through mitochondria but not
through NADPH oxidase system.
TGF-β1 is synthesized as 55-kDa precursor polypeptides, which is
cleaved in the cells by proteases to form bioactive TGF-β1 (Dubois
et al., 1995). There are several mammalian proprotein convertases
that can process pro-TGF-β1 into bioactive TGF-β1 (Dubois et al.,
1995). Furin and TSP-1 are the best characterized members of the
mammalian proprotein convertase family and are responsible for pro-
TGF-β1 proteolytic processing (Annes et al., 2003). Furin and TSP-1
are upregulated in various cancers including hepatocellular carcinoma
(Kazerounian et al., 2008; Paradis et al., 2005). In this study, we
observed an increase in furin and TSP-1 expression (Figs. 6A–C). We
also observed the decreased secretion of TGF-β1 from HCV-infected
Fig. 5. (A) Effect of HCV-induced Ca2+ signaling and ROS on TGF-β1 promoter activity. Huh-7 cells were transfected with 500 ng of the wild-type TGF-β1 promoter luciferase
reporter (phTG1 −1362/+11). At 36 h posttransfection cells were incubated with Ca2+ chelator BAPTA-AM, TMB-8, EGTA, ruthenium red, or antioxidant PDTC, or DPI at a ﬁnal
concentration of 20 μM for 12 h. Cellular lysates were subjected to dual luciferase reporter assay. The values represent the means±standard deviations of three independent
experiments performed in triplicate. * denotes pb0.05 compared to mock-infected Huh-7 cells. ** denotes pb0.05 compared to HCV-infected mock-treated cells. (B) Effect of HCV-
induced Ca2+ signaling and ROS on transcriptional stimulation of TGF-β1mRNA. Mock- and HCV-infected cells were treated with calcium chelators, antioxidants as described above.
Total cellular RNAwas extracted and the TGF-β1 mRNAwas analyzed using TGF-β1-speciﬁc primers and SYBR green probe. The values represent the means±standard deviations of
three independent experiments performed in triplicate. * denotes pb0.05 compared to mock-infected Huh-7 cells. ** denotes pb0.05 compared to HCV-infected mock-treated cells.
291L.D. Presser et al. / Virology 412 (2011) 284–296Huh-7 cells silenced with furin or TSP-1 speciﬁc siRNA, suggesting a
potential role of furin and TSP-1 in TGF-β1 proteolytic processing.
Furin is a Ca2+ dependent serine protease and in our model Ca2+
efﬂux occurs from the ER in HCV-infected cells arguing that HCV-
induced Ca2+ signaling induces furin which can lead to the proteolytic
processing of latent TGF-β1 into bioactive TGF-β1 (Fig. 9, model). TSP-
1 is a protein associated with tissue remodeling. In some tumor cells,
a positive feedback loop between TSP-1 and TGF-β1 may exist as
active TGF-β1 induces TSP-1 expression through several pathways
(Kazerounian et al., 2008). Similar to furin, recent studies of a
polymorphism in human TSP-1 suggest that Ca2+-induced confor-
mational changes regulate some of TSP-1 physiological functions such
as altered interactions of TSP-1 with various ligands (Calzada et al.,
2008). These studies suggest that intracellular increases in Ca2+ levels
can activate TSP-1 and/or furin, which can lead to proteolytic
processing of TGF-β1 in HCV-infected cells.
Previous studies have shown the increase of respiratory syncytial
virus and JC virus replication by TGF-β1 (McCann and Imani, 2007;
Ravichandran et al., 2007). The role of TGF-β1 in HCV replication is not
clearly deﬁned. Recently, the stimulation as well as suppression of
HCV replication by exogenous addition of TGF-β1 has been demon-
strated in HCV replicon system (Lin et al., 2008; Murata et al., 2005).
However, the regulation of HCV replication by endogenous TGF-β1
has not been studied. Recently, endogenous TGF-β1 has been shown
to induce intracellular signaling pathways including activation of
hypoxia inducible factor-1 (HIF-1) and direct interaction of TGF-β1with STAT-5 leading to liver ﬁbrosis (Hosui et al., 2009; McMahon
et al., 2006). Our results show that furin, TSP-1, and TGF-β1 positively
regulate HCV replication. We argue that the formation and proper
processing of TGF-β1 through furin or TSP-1 in HCV-infected cells can
positively regulate HCV replication that may include the activation of
signaling pathways.
In summary, we show that ER stress mediated Ca2+ efﬂux
followed by oxidative stress-induced stimulation and proteolytic
activation of TGF-β1 in HCV infected cells positively regulate HCV
replication. These studies provide greater insight into the role of HCV
in liver ﬁbrosis. The role TGF-β1 and intracellular signaling events in
HCV infected cells provide the extensive knowledge regarding the
mechanisms of liver ﬁbrosis. The results of these studies open new
avenues for alternative strategies in the treatment of chronic HCV
infection associated with liver ﬁbrosis.
Materials and methods
Expression plasmids
The TGF-β1 promoter luciferase reporter plasmid (phTG1−1362/
+11) was kindly provided by Dr. S. J. Kim (NCI, Bethesda, MD). The
infectious JFH-1 cDNA (HCV genotype 2a) along with the replication-
defective JFH-1/GND construct was obtained from Dr. T. Wakita
(Tokyo, Japan). The infectious J6/JFH-1 cDNA (HCV genotype 2a) was
obtained from Dr. C. Rice (Rockefeller University, New York City, NY).
Fig. 6. (A) HCV-infection induces proprotein convertases. Total cellular RNA was extracted from mock-infected and HCV-infected Huh-7 cells, followed by cDNA synthesis and
quantitative RT-PCR analysis using furin, MMP-9, calpain, and TSP-1 speciﬁc primers. The data shown here represent the means±standard deviations of at least three independent
experiments performed in triplicate. * denotes pb0.05 compared to mock-infected Huh-7 cells. (B) HCV-infection induces furin protein expression, secretion of TSP-1, and
proteolytic activation of TGF-β1. Mock-and HCV-infected cellular lysates were immunoblotted with antibodies against furin, TSP-1, TGF-β1, HCV NS3, albumin, and actin. (C) Mock-
infected and HCV-infected cells were grown in eight-well chamber slides. The cells were ﬁxed, permeabilized, and stained with furin, TGF-β1, and HCV NS3 antibodies. DAPI was
used as a nuclear stain. Bar, 5 μm.
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S1165A, and pFlag-NS3/4A Δ1487–1501 (ΔArg) were kindly provided
by Dr. M. Gale (University of Washington, Seattle, WA) (Johnson et al.,
2007). The wild-type HCV NS5A and various mutants, core, and NS5B
expression vectors were obtained from Dr. A. Siddiqui (UC San Diego,
CA), E1/E2 from Dr. J. Dubuisson (HHMI, France), and NS4B (Dr. K.
Konan, Pennsylvania State University, PA).
Cell lines
The human hepatoma cell line Huh-7 was obtained from A.
Siddiqui, UCSD, CA, and Huh7.5 subline was obtained from Dr. C. Rice,
Rockefeller University, NY (Blight et al., 2002). These cells were grown
in Dulbecco's modiﬁed Eagle's medium (DMEM) supplemented with
10% fetal calf serum, 100 U of penicillin/ml, and 100 μg of
streptomycin sulfate/ml. For cells supporting subgenomic replicons,
G418 (Geneticin; Gibco-BRL) at 750 μg/ml was added to the culture
medium.
HCV cell culture infection system
The plasmid pFL-J6/JFH1 encoding the HCV J6/FJH-1 strain
genome was transcribed and delivered into Huh7.5 cells by
electroporation (Burdette et al., 2010; Zhong et al., 2005). The
cell-free virus was propagated in Huh-7.5 cell cultures, as describedpreviously (Lindenbach et al., 2005). The expression of HCV protein
was analyzed using western blot assays. The HCV cell culture
supernatant was collected at appropriate time points and used to
infect naive Huh-7 cells at appropriate dilutions (moi=1) for 5–6 h
at 37 °C and 5% CO2 (Waris et al., 2007; Burdette et al., 2010). The
viral titer in cell culture supernatant was expressed as focus forming
unit (ffu) ml−1, which was determined by the average number of
HCV-NS5A-positive foci detected at the highest dilutions as
described previously (Zhong et al., 2005).
Western blot and antibodies
Mock-infected and HCV-infected Huh-7 cells were harvested and
cellular lysates were prepared by incubating in radioimmune
precipitation (RIPA) buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 1%
NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM sodium orthova-
nadate, 1 mM sodium formate, and 10 μl/ml protease inhibitor
cocktail) (Thermo Scientiﬁc, IL) for 30 min on ice. The samples were
subjected to SDS-PAGE. Gels were electroblotted on to nitrocellulose
membrane (Thermo Scientiﬁc, IL) in 25 mM Tris, 192 mM glycine and
20% methanol. Membranes were incubated for 1 h in blocking buffer
[20 mM Tris–HCl, pH 7.5, 150 mM NaCl, 0.5% Tween-20, 5% dry milk],
probed with primary antibody for 1 h at room temperature (RT) and
washed twice for 10 min with blocking buffer without milk followed
by incubation with secondary antibody for 1 h at RT. After an
Fig. 7. (A) Effect of siRNAs on target gene expression. Huh-7 cells were transfected with siRNAs against GFP, TGF-β1, furin, and TSP-1. Total cellular RNA was extracted, and
quantitative RT-PCR was performed using furin, TSP-1, and TGF-β1 speciﬁc primers. The data shown here represent the means±standard deviations of at least three independent
experiments performed in triplicate. * denotes pb0.05 compared to mock-infected cells transfected with control GFP siRNA. (B) Effect of TGF-β1, furin and TSP-1 siRNAs on TGF-β1
secretion. Mock-infected and HCV-infected Huh-7 cells were transfected with siRNA against TGF-β1, furin, and TSP-1 as described above. Cell culture supernatant was collected and
the total secreted TGF-β1 protein was determined by ELISA. The data shown here represent the means±standard deviations of at least three independent experiments performed in
triplicate. * denotes pb0.05 compared tomock-infected control cells. ** denotes pb0.05 compared to HCV-infected cells. (C) Effect of TGF-β1, furin or TSP-1 siRNAs on bioactive TGF-
β1 secretion. Mock-infected and HCV-infected Huh-7 cells were transfected with siRNA against TGF-β1, furin, or TSP-1 as described above. Cell culture supernatant was collected and
subjected to growth inhibition assay usingmink lung epithelial cells as described inMaterials andmethods. The data shownhere represent themeans±standard deviations of at least
three independent experiments performed in triplicate. * denotes pb0.05 compared to mock-infected cells. ** denotes pb0.05 compared to HCV-infected mock-transfected cells.
Fig. 8. (A) Effect of furin, TSP-1 and TGF-β1 siRNAs on HCV replication. Mock-infected and HCV-infected Huh-7 cells were transfected with furin, TSP-1, and TGF-β1 siRNAs as
described above. Total cellular RNA was extracted and the levels of HCV RNA were determined by quantitative RT-PCR. The data shown here represent the means±standard
deviations of at least three independent experiments performed in triplicate. * denotes pb0.05 compared tomock-infected control cells. ** denotes pb0.05 compared to HCV-infected
cells. (B) Effect of TGF-β1, furin and TSP-1 siRNAs on mock-infected and HCV-infected Huh-7 cell proliferation. Mock-infected and HCV-infected Huh-7 cells were transfected with
siRNA against TGF-β1, furin, and TSP-1 as described above. At 48 h posttransfection cells were subjected to cell proliferation assay as described in Materials and methods. The data
shown here represent themeans±standard deviations of at least three independent experiments performed in triplicate. * denotes pb0.05 compared tomock-infected control cells.
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Fig. 9. Model illustrating the mechanism of activation of TGF-β1 and its downstream pathways. HCV gene expression in the ER leads to the efﬂux of Ca2+, which is subsequently
taken up by the mitochondria. The elevated concentration of Ca2+ in the mitochondria induces ROS, which induces TGF-β1. The latent form of TGF-β1 is then proteolytically cleaved
by proprotein convertases (furin, TSP-1) and the active form is secreted from the hepatocytes.
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visualized using the Odyssey Infrared Imaging System (Li-Cor
Biosciences, Lincoln, NE).
All the primary antibodies were used according to the manufac-
turer's protocol: HCV NS3 (Virogen, Watertown, MA), HCV core
(Afﬁnity BioReagents, Rockford, IL), HCV E1/E2 (a kind gift of Dr.
Dennis Burton, TSRI, San Diego, CA), HCV NS4B (Virogen, Watertown,
MA), HCV NS5A (Virogen, Watertown, MA), HCV NS5B (Alexis
Biochemicals, Plymouth, PA) Actin (Thermo Scientiﬁc, Rockford, IL),
Flag (Sigma, St. Louis, MO), furin (Santa Cruz, Santa Cruz, CA), TSP-1
(Santa Cruz, Santa Cruz, CA), albumin (MBL International, Woburn,
IL), and TGF-β1 (Cell Signaling, Danvers, MA).
Immunoﬂuorescence assay
Huh-7 cells in eight-well chamber slides (Nalgene Nunc) were
serum starved overnight, and incubated with HCV virion (moi=1) for
5–6 h at 37 °C. The cells were washed with PBS, ﬁxed with 4%
paraformaldehyde for 10 min at RT, permeabilized for 5 minwith 0.2%
Triton X-100, and blocked for 45 min with 5% bovine serum albumin
in PBS. The cells were next incubated with primary antibodies for 1 h
at RT, followed by incubation with secondary antibodies (anti-mouse
Alexa Fluor 633, anti-goat Alexa Fluor 546 or anti-rabbit Alexa Fluor
488) (Molecular Probes, Eugene, OR) for 1 h. After being washed with
PBS, cells were mounted with antifade reagent containing DAPI (4, 6-
diamidino-2 phenylindole) (Invitrogen, CA) and observed under a
ﬂuorescence microscope equipped with the Nikon MetaMorph digital
imaging system.
RNA interference
Huh-7 cells were transfected with siRNAs against TGF-β1, furin,
TSP-1 and GFP according to the manufacturer's protocol (Santa Cruz
Biotechnology Inc., Santa Cruz, CA). Each siRNA consists of pools of
three to ﬁve target-speciﬁc 19–25 nt siRNA designed to knockdown
the target gene expression. For each transfection, two solutions were
prepared. Solution A: 60 pmol of siRNA duplex was mixed with 100 μl
siRNA transfection medium. Solution B: 6 μl of transfection reagent
was added to 100 μl siRNA transfection medium. Solutions A and B
were allowed to incubate at RT for 20 min. After 20 min, solutions A
and B were combined, and allowed to incubate another 20 min at RT.The combined solutionswere then added to the cells in six well plates,
and then incubated for 5 h at 37 °C and 5% CO2, and the transfection
solution replaced with complete DMEM growth media.
Luciferase assay
Mock-infected and HCV-infected Huh-7 cells were transfected and
at 30 h post-transfection, cells were serum starved overnight followed
by treatment with 20 μM of PDTC, BAPTA-AM, NAC, ruthenium red,
TMB-8, EGTA, and DPI for 12 h. Cells were harvested and cellular
lysates were analyzed for luciferase activity using the dual-luciferase
reporter assay kit (Promega, WI). All transfections included a renilla
expression vector to serve as an internal control. All the inhibitors
were obtained from Calbiochem-Novabiochem Corp, San Diego, CA.
Detection of intracellular ROS
Mock-infected and HCV-infected cells were washed with PBS and
then incubated with 10 μM carboxy derivative of ﬂuorescein (CM-
H2DCFDA) (Invitrogen, CA) in warm PBS for 1 h. Cells were treated
with BAPTA-AM, TMB-8, and ruthenium red, at 20 μM for 12 h,
harvested and washed two times with PBS and ﬁnally suspended in
300 μl of PBS. Huh-7 cells treated for 10 min with 500 μM H2O2 was
used as a positive control. ROS levels were measured using a BD LSR-II
ﬂow cytometer. For microscopy, semi-conﬂuent mock-infected and
HCV-infected cells were washed with PBS and incubated with 10 μM
of CM-H2DCFDA in serum free medium at 37 °C, 5% CO2 for 1 h. Cells
were washed two times with PBS and visualized under the
microscope. Huh-7 cells treated for 10 min with 500 μM H2O2 was
used as a positive control. ROS levels were visualized at 488 nm using
a Nikon Eclipse TE2000-S inverted microscope and MetaMorph
software.
Cytokine array
Sub-conﬂuent mock-infected and HCV-infected Huh-7 cells were
washed 3 times with PBS, and allowed to culture in DMEM containing
0.2% FBS for 24 h. The cell culture supernatant (conditioned medium)
from mock-infected and HCV-infected Huh-7 cells were harvested,
and centrifuged at 1000 rpm for 10 min to remove cell debris and
subjected to cytokine array using a human cytokine array kit according
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analysis of the cytokine array blot was performed to determine the
difference in the release of human cytokines from cells. The values
were normalized to identical background levels using the Ray Bio
Human Cytokines antibody array V analysis tool.
TGF-β1 ELISA
The cell culture supernatant from sub-conﬂuent mock-infected
and HCV-infected Huh-7 cells were harvested, and prepared by
centrifugation at 1000 rpm for 10 min to remove cell debris. The
secreted TGF-β1 protein in cell culture supernatant from mock-
infected and HCV-infected Huh-7 cells was determined by ELISA
according to the manufacturer's protocol (Promega, WI). For
activation 20 μl of 1 N HCl was added to 0.8 ml of cell culture
supernatant, mixed, and incubated for 10 min at room temperature.
The samples were neutralized by adding 30 μl 5 M NaOH, mixed, and
used immediately for the sandwich TGF-β1 ELISA. A standard curve
was constructed by using serial dilutions of human recombinant TGF-
β1. TGF-β1 levels were measured in triplicate determinations.
Measurement of bioactive TGF-β1 by mink lung epithelial cell (MLEC)
luciferase assay
Mink lung epithelial cells containing bioactive TGF-β1 sensitive
plasminogen activator inhibitor promoter luciferase construct (PAI/L)
was a kind gift from Dr. D.B. Rifkin, NYU, New York, NY. The assay is
based on the ability of bioactive TGF-β1 to bind tomink lung epithelial
cells receptors. This results in a dose-dependent increase in luciferase
activity. Brieﬂy, mink lung epithelial cells were plated on 96 well
plates at a concentration of 2.5×105 cells per well and incubated for
24 h at 37 °C. These cells were grown in DMEM supplemented with
10% fetal calf serum, 100 U of penicillin/ml, and 100 μg of
streptomycin sulfate/ml. Cells were washed twice with PBS, and
50 μl of reporter lysis buffer (Promega, Madison,WI) was added to the
wells. Twenty microliters of cell extract and 90 μl of luciferase assay
reagent were added to 96 well white opaque ﬂat bottom plate and
light emission is measured for 10 s in a Bio-TEK Synergy HT Multi-
Detection microplate reader. TGF-β1 standards were prepared by
adding 500 μl of 0.2% FBS DMEM into a polypropylene tube. The
standard stock solution is then serially diluted to obtain standards
from 1000 pg/ml to 125 pg/ml.
Quantitative real-time RT-PCR
Total RNA was extracted from mock-infected and HCV-infected
Huh-7 cells using TRIzol (Invitrogen, CA). HCV RNA was quantiﬁed by
real-time RT-PCR using an ABI PRISM 7500 Sequence Detector
(Applied Biosystems, CA). Ampliﬁcations were conducted in duplicate
using the following primers and 6-carboxyﬂuorescein (6FAM)- and
tetrachloro-6-carboxyﬂuorescein (TAMRA)-labeled probes (Applied
Biosystems, CA): HCV Taqman probe, 5′-6FAM-CTG CGG AAC CGG
TGA GTA CAC-TAMRA-3′; HCV sense primer— CGG GAG AGC CAT AGT
GG; HCV antisense primer — AGT ACC ACA AGG CCT TTC G. The
sequences for the primers and probes were designed using Primer
Express software (Applied Biosystems, CA). The human glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) gene was used as an
internal control (Applied Biosystems, CA). Ampliﬁcation reactions
were performed in a 25 μl mix using RT-PCR core reagents kit and the
template RNA. Reactions were performed in a 96-well spectroﬂuoro-
metric thermal cycler under the following conditions: 2 min at 50 °C,
30 min at 60 °C, 10 min at 95 °C, 44 cycles of 20 s at 95 °C and 1 min at
62 °C. Fluorescence was monitored during every PCR cycle at the
annealing step. At the termination of each PCR run, the data was
analyzed by the automated system and ampliﬁcation plots were
generated.SYBR green PCR
The expression of cellular genes in mock-infected and HCV-
infected Huh-7 cells was quantiﬁed by real-time RT-PCR using the
following primers. TGF-β1, sense primer — CAA CAA TTC CTG GCG
ATA CC; antisense primer — GAA CCC GTT GAT GTC CAC TT: furin,
sense primer — GAG ATT GAA AAC ACC AGC GAA; antisense primer —
GCG GTG CCA TAG AGT ACG AG: TSP-1, sense primer — GTG TTT GAC
ATC TTT GAA CTC; antisense primer — CCA AAG ACA AAC CTC ACA
TTC: calpain, sense primer — CCG GGA CTT CAT ACG TGA GT;
antisense primer — AGG TGC CCT CGT AAA ATG TG: MMP-9, sense
primer — CGC CGC TCA CCT TCA C; antisense primer — GCC CAG GGA
CCA CAA CT: 18s, sense primer — ACA TCC AAG GAA GGC AGC AG;
antisense primer— TCG TCA CTA CCT CCC CGG. Total cellular RNAwas
extracted using TRIzol and DNase treated using RQ1 RNase-free DNase
prior to cDNA production. The cDNA was reverse-transcribed from
1 μg of total RNA using oligo(dT) primers. Quantitative RT-PCR was
carried out by using SYBR green master mix and speciﬁc primer sets.
Ampliﬁcation reactions were performed under the following condi-
tions: 2 min at 50 °C, 10 min at 95 °C, 40 cycles for 15 s at 95 °C, and
1 min at 60 °C. Relative transcript levels were calculated using ΔΔCt
method as speciﬁed by the manufacturer.
Non-radioactive cell proliferation assay (MTT assay)
Cell proliferation assay was performed according to the manufac-
turer's protocols (Promega, Madison, WI). Mock-infected and HCV-
infected cells, transfected with TGF-β1, TSP-1, or furin siRNA were
plated in 96-well culture plates and incubated at 37 °C, 5% CO2 for
24 h. Following incubation, 15 μl cell proliferation dye was added to
the cells and was incubated at 37 °C, 5% CO2 for 4 h. One hundred
microliter stop solution was added and absorbance was read at
570 nm and 650 nm. Absorbance was measured in triplicate.
Statistical analysis
Error bars show the standard deviations of the means of data from
three individual trials. Two-tailed unpaired t-tests were used to
compare experimental conditions to those of the respective controls.
The signiﬁcance level was set at α value of 0.05.
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